Daniel Camilo Aguirre-Acevedo

Daniel Camilo Aguirre-Acevedo

Auto-generated profile, based on publicly available information

Daniel Camilo Aguirre-Acevedo

Universidad de Antioquía

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in Health Research Policy and Systems
Verified
Journal Article
Open access
PDF file
VCVerónica Ciro Correa
Verónica Ciro Correa
LLLuz Helena Lugo-Agudelo
Luz Helena Lugo-Agudelo
DADaniel Camilo Aguirre-Acevedo
Daniel Camilo Aguirre-Acevedo
JPJesús Alberto Plata
Jesús Alberto Plata
ABAna María Posada Borrero
Ana María Posada Borrero
DVDolly Andrea Castaño Valencia
Dolly Andrea Castaño Valencia
Introduction: Clinical practice guidelines (CPGs) are designed to improve the quality of care and reduce unjustified individual variation in clinical practice. Knowledge of the barriers and facilitators that influence the implementation of the CPG recommendations is the first step in creating strategies to improve health outcomes. The present systematic meta-review sought to explore the barriers and facilitators for the implementation of CPGs. Methods: A search was conducted in the PubMed, Embase, Cochrane, Health System Evidence and International Guideline Library (G-I-N) databases. Systematic reviews of qualitative, quantitative or mixed-methods studies that identified barriers or facilitators for the implementation of CPGs were included. The selection of the title and abstract, the evaluation of the full text, extraction of the data and the quality assessment were carried out by two independent reviewers. To summarise the evidence, we grouped the barriers and facilitators according to the following contexts: political and social, health organisational system, guidelines, health professionals and patients. Results: Overall, 25 systematic reviews were selected. The relevant barriers in the social-political context were the absence of a leader, difficulties with teamwork and a lack of agreement with colleagues. Relevant barriers in the health system were a lack of time, financial problems and a lack of specialised personnel. Barriers of the CPGs included a lack of clarity and a lack of credibility in the evidence. Regarding the health professional, a lack of knowledge about the CPG and confidence in oneself were relevant. Regarding patients, a negative attitude towards implementation, a lack of knowledge about the CPG and sociocultural beliefs played a role. Some of the most frequent facilitators were consistent leadership, commitment of the members of the team, administrative support of the institution, existence of multidisciplinary teams, application of technology to improve the practice and education regarding the guidelines. Conclusions: The barriers and facilitators described in this review are factors that influence the implementation of evidence in clinical practice. Knowledge of these factors should contribute to the development of a theoretical basis for the creation of CPG implementation strategies to improve professional practice and health outcomes for patients.

1 March 2011 in The Lancet Neurology
Verified
Journal Article
Closed access
NANatalia Acosta-Baena
Natalia Acosta-Baena
DSDiego Sepulveda-Falla
Diego Sepulveda-Falla
CLCarlos Mario Lopera-Gómez
Carlos Mario Lopera-Gómez
MJMario César Jaramillo-Elorza
Mario César Jaramillo-Elorza
SMSonia Moreno
Sonia Moreno
FLFrancisco Lopera
Francisco Lopera

1 April 2016 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
DADaniel C. Aguirre-Acevedo
Daniel C. Aguirre-Acevedo
FLFrancisco Lopera
Francisco Lopera
EHEliana Henao
Eliana Henao
VTVictoria Tirado
Victoria Tirado
CMClaudia Muñoz
Claudia Muñoz
FJFabian Jaimes
Fabian Jaimes
Research diagnostic criteria have been published for preclinical Alzheimer disease (AD) based on biomarkers of AD-related neurodegeneration.1 The study of carriers of AD-causing mutations provides a unique opportunity to characterize the preclinical changes associated with predisposition to AD.

1 June 2009 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
JBJorge H. Botero-Garcés
Jorge H. Botero-Garcés
GGGisela M. García-Montoya
Gisela M. García-Montoya
DGDayvin Grisales-Patiño
Dayvin Grisales-Patiño
DADaniel C. Aguirre-Acevedo
Daniel C. Aguirre-Acevedo
MÁMartha C. Álvarez-Uribe
Martha C. Álvarez-Uribe
Giardia intestinalis infection is prevalent throughout the world and widely distributed in developing countries. In general, children display serious consequences to their state of health, including slow height-weight development; therefore, the main aim of this study was to determine the association between Giardia infection and the nutritional status of children who participate in the program of complementary feeding (Mejoramiento Alimentario y Nutricional de Antioquia (MANA) - Instituto Colombiano de Bienestar Familiar (ICBF)). A cross-sectional study examining the association of giardiasis with nutritional status was conducted. A total of 2035 children aged eight months to six years-old were studied. Data were collected using structured questionnaires, anthropometric measurements and laboratory analysis of blood and stool samples. Analysis of the results showed that 27.6% of children were infected with G. intestinalis, while 8.1% and 1.9% were mildly and significantly underweight, respectively, and 14.1% presented stunting. Giardiasis was statistically identified as a strong predictor of stunting in this study population.

19 June 2012 in Molecular Psychiatry
Verified
Journal Article
Open access
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
SCS C Chandrasekharappa
S C Chandrasekharappa
EHE Henao
E Henao
AMA F Martinez
A F Martinez
UHU Harper
U Harper
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
The literature on GWAS (genome-wide association studies) data suggests that very large sample sizes (for example, 50,000 cases and 50,000 controls) may be required to detect significant associations of genomic regions for complex disorders such as Alzheimer's disease (AD). Because of the challenges of obtaining such large cohorts, we describe here a novel sequential strategy that combines pooling of DNA and bootstrapping (pbGWAS) in order to significantly increase the statistical power and exponentially reduce expenses. We applied this method to a very homogeneous sample of patients belonging to a unique and clinically well-characterized multigenerational pedigree with one of the most severe forms of early onset AD, carrying the PSEN1 p.Glu280Ala mutation (often referred to as E280A mutation), which originated as a consequence of a founder effect. In this cohort, we identified novel loci genome-wide significantly associated as modifiers of the age of onset of AD (CD44, rs187116, P=1.29 × 10−12; NPHP1, rs10173717, P=1.74 × 10−12; CADPS2, rs3757536, P=1.54 × 10−10; GREM2, rs12129547, P=1.69 × 10−13, among others) as well as other loci known to be associated with AD. Regions identified by pbGWAS were confirmed by subsequent individual genotyping. The pbGWAS methodology and the genes it targeted could provide important insights in determining the genetic causes of AD and other complex conditions.

27 February 2018 in Trials
Verified
Journal Article
Open access
PDF file
JGJaime Gallo-Villegas
Jaime Gallo-Villegas
JAJuan Aristizabal
Juan Aristizabal
MEMauricio Estrada
Mauricio Estrada
LVLuis H. Valbuena
Luis H. Valbuena
RNRaul Narvaez-Sanchez
Raul Narvaez-Sanchez
JCJuan C Calderón
Juan C Calderón
Evidence of the efficacy of high-intensity, low-volume interval training (HIIT-low volume) in treating insulin resistance (IR) in patients with metabolic disorders is contradictory. In addition, it is unknown whether this effect is mediated through muscle endocrine function, which in turn depends on muscle mass and fiber type composition. Our aims were to assess the efficacy of HIIT-low volume compared to continuous aerobic exercise (CAE) in treating IR in adults with metabolic syndrome (MS) and to establish whether musclin, apelin, muscle mass and muscle composition are mediators of the effect. This is a controlled, randomized, clinical trial using the minimization method, with blinding of those who will evaluate the outcomes and two parallel groups for the purpose of showing superiority. Sixty patients with MS and IR with ages between 40 and 60 years will be included. A clinical evaluation will be carried out, along with laboratory tests to evaluate IR (homeostatic model assessment (HOMA)), muscle endocrine function (serum levels of musclin and apelin), thigh muscle mass (by dual energy x-ray absorptiometry (DXA) and thigh muscle composition (by carnosine measurement with proton magnetic resonance spectroscopy (1H–MRS)), before and after 12 weeks of a treadmill exercise program three times a week. Participants assigned to the intervention (n = 30) will receive HIIT-low volume in 22-min sessions that will include six intervals at a load of 90% of maximum oxygen consumption (VO2 max) for 1 min followed by 2 min at 50% of VO2 max. The control group (n = 30) will receive CAE at an intensity of 60% of VO2 max for 36 min. A theoretical model based on structural equations will be proposed to estimate the total, direct and indirect effects of training on IR and the proportion explained by the mediators. Compared with CAE, HIIT-low volume can be effective and efficient at improving physical capacity and decreasing cardiovascular risk factors, such as IR, in patients with metabolic disorders. Studies that evaluate mediating variables of the effect of HIIT-low volume on IR, such as endocrine function and skeletal muscle structure, are necessary to understand the role of skeletal muscle in the pathophysiology of MS and their regulation by exercise. NCT03087721 . High-intensity Interval, Low Volume Training in Metabolic Syndrome (Intraining-MET). Registered on 22 March 2017, retrospectively registered.